Relevant bibliographies by topics / Alopecia and scalp psoriasis

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Alopecia and scalp psoriasis'

Author: Grafiati
Published: 7 June 2025
Last updated: 9 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Alopecia and scalp psoriasis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Alopecia and scalp psoriasis"

1

Almeida, Maiana Carneiro, Ricardo Romiti, Isabella Doche, Neusa Yuriko Sakai Valente, and Aline Donati. "Psoriatic scarring alopecia." Anais Brasileiros de Dermatologia 88, no. 6 suppl 1 (2013): 29–31. http://dx.doi.org/10.1590/abd1806-4841.20132241.

Full text
Abstract:
Psoriasis is a relatively frequent inflammatory dermatosis. Scarring alopecia due to scalp psoriasis was first reported in 1972, but few reports have been written since then, showing that this is a very rare complication of a common disorder. We report a young Brazilian woman with longstanding scalp psoriasis, which progressed to scaring alopecia.
APA, Harvard, Vancouver, ISO, and other styles
2

Iamsumang, Wimolsiri, Tueboon Sriphojanart, and Poonkiat Suchonwanit. "Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus." Case Reports in Dermatology 9, no. 1 (2017): 51–59. http://dx.doi.org/10.1159/000462958.

Full text
Abstract:
Psoriasis is a chronic, recurrent, and relatively common inflammatory dermatologic condition, which demonstrates various clinical manifestations including hair loss. It was once believed that alopecia was not a presentation of scalp psoriasis, but it is now widely accepted that psoriatic alopecia exists. Although the majority of patients get hair regrowth, it can potentially lead to permanent hair loss. Herein, we report a case of 26-year-old female patient with systemic lupus erythematosus who presented with scalp hair loss and nonpruritic scaly plaques on the scalp. Her clinical presentation, dermoscopic, and histopathologic findings were consistent with psoriatic alopecia. Additionally, we also described a novel scalp dermoscopic pattern of “patchy dotted vessels” which we detected in the lesion of scalp psoriasis.
APA, Harvard, Vancouver, ISO, and other styles
3

Wright, A. L., and A. G. Messenger. "Scarring alopecia in psoriasis." Acta Dermato-Venereologica 70, no. 2 (1990): 156–59. http://dx.doi.org/10.2340/0001555570156159.

Full text
Abstract:
Scalp biopsies were taken from 3 patients with a scarring alopecia associated with severe scalp psoriasis. The histological findings in each case showed inflammatory destruction of the infundibular region of the hair follicle. The similarity of these changes in each case strongly suggests an association with the psoriasis.
APA, Harvard, Vancouver, ISO, and other styles
4

Cockayne, S. E., and A. G. Messenger. "Familial scarring alopecia associated with scalp psoriasis." British Journal of Dermatology 144, no. 2 (2001): 425–27. http://dx.doi.org/10.1046/j.1365-2133.2001.04046.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Larson, Krista N., Jaclyn Smith, Leah A. Cardwell, and Steven R. Feldman. "Scalp psoriasis associated with central centrifugal cicatricial alopecia." Journal of Dermatology & Dermatologic Surgery 21, no. 1 (2017): 31–34. http://dx.doi.org/10.1016/j.jdds.2016.08.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Fuentelsaz-del Barrio, V., V. Parra-Blanco, P. Borregón-Nofuentes, and R. Suárez-Fernández. "Lipedematous Alopecia in a Patient With Scalp Psoriasis." Actas Dermo-Sifiliográficas (English Edition) 103, no. 6 (2012): 551–54. http://dx.doi.org/10.1016/j.adengl.2012.07.013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Divya, G., and Jayakar Thomas. "Twenty nail dystrophy with alopecia areata in an atopic child." International Journal of Research in Dermatology 5, no. 2 (2019): 416. http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20191772.

Full text
Abstract:
<p class="abstract">Twenty nail dystrophy mainly describes roughness of nail which can be idiopathic or it could be associated with various other dermatological conditions like psoriasis, alopecia areata and eczema. Here we report a case of twenty nail dystrophy with alopecia areata of scalp in a 6-year-old child.</p>
APA, Harvard, Vancouver, ISO, and other styles
8

Morgado, Francisca, and Rui Oliveira Soares. "Influência da Disbiose na Patologia do Couro Cabeludo." Journal of the Portuguese Society of Dermatology and Venereology 79, no. 4 (2021): 309–14. http://dx.doi.org/10.29021/spdv.79.4.1420.

Full text
Abstract:

 
 
 In recent years, several studies have demonstrated the involvement of the intestinal microbiota in immune-mediated diseases such as diabetes, ulcerative colitis, and multiple sclerosis. There are few data on the follicular microbiome and its role in the pathogenesis of scalp diseases. Some studies show influence of dysbiosis on these diseases, and manipulation of the microbiome may represent a possible therapeu- tic option. This article reviews current knowledge regarding the impact of dysbiosis on dermatological diseases of the scalp, such as seborrheic dermatitis, psoriasis, alopecia areata, androgenetic alopecia, lichen planus pilaris, frontal fibrosing alopecia and decalvant folliculitis. A broader understanding of this may suggest additional treatments beyond conventional therapies.
 
 
APA, Harvard, Vancouver, ISO, and other styles
9

Sushama Narlewad and D.V. Hange. "Ayurvedic management of Alopecia Areata - A Single Case Study." Journal of Ayurveda and Integrated Medical Sciences 8, no. 12 (2024): 284–90. http://dx.doi.org/10.21760/jaims.8.12.43.

Full text
Abstract:
Alopecia areata is defined as patches of hair loss on the scalp. It is considered a psychosomatic disorder in present era. Today, the young generation is more likely to be victims of Alopecia areata, based on clinical grounds. There are many causes of alopecia areata, such as fungal infection, dandruff, scalp psoriasis, seborrheic dermatitis, pediculosis, systemic disorders, autoimmune disorders, etc. It may also be seen as a side effect of chemotherapy or radiotherapy. A 16-year-old patient had patches of hair loss on his scalp. He had taken treatment with conventional modern medicine, but in vain. The patient was given Ayurvedic treatment for six months on an OPD basis, including Karanj oil for local application, Rakt Pachak Churna, Rasayan Churna, Aarogyavardhini Vati, and Jalaukavacharan (leech therapy). After a 3-months interval, regrowth of the hair was found. This study suggests that Shaman and Shodhan treatment can provide noteworthy relief in Alopecia areata, i.e., Indralupta.
APA, Harvard, Vancouver, ISO, and other styles
10

Todberg, Tanja, Nikolai Dyrberg Loft, and Claus Zachariae. "Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report." Case Reports in Dermatology 12, no. 2 (2020): 150–54. http://dx.doi.org/10.1159/000508782.

Full text
Abstract:
Alopecia areata (AA) is the most common immune-mediated hair loss disorder with a life-time prevalence of 2%. The pathogenesis of AA is not completely understood, but interferon gamma (INF-γ) and Janus kinases (JAK) may play a key role. Here, we present a case involving a male patient with psoriasis and psoriatic arthritis, who exhibited a rapid hair loss, diagnosed as AA, during ciclosporin treatment. As ciclosporin was unable to control his psoriasis, the treatment was changed to methotrexate injections, but the hair loss progressed into alopecia universalis. During treatment with the oral JAK inhibitor tofacitinib, the patient presented an almost complete hair remission on the scalp and partly on the eyebrows, eyelashes, beard, and chest. Furthermore, the patient experienced no joint complaints and his psoriasis was improved. Based on these findings, JAK inhibitors may be an optional treatment in complicated cases involving both rheumatological and dermatological diseases.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Alopecia and scalp psoriasis"

1

Kolivras, Athanassios. "Immunohistochemistry in the histopathological diagnosis of primary scalp alopecia." Doctoral thesis, Universite Libre de Bruxelles, 2016. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/238160.

Full text
Abstract:
Primary scalp alopecia is classically divided into cicatricial (scarring) and non-cicatricial (non-scarring). Challenging cases are assessed with a scalp biopsy. The use of both horizontal and vertical sections (HoVert sections) has dramatically improved the accuracy of histopathological diagnosis. In this work, we have used immunostaining to address diagnostic difficulties, which persist despite all currently available tools. We performed an immunostain panel (CD3, CD4, CD8 and CD20) in order to distinguish pattern hair loss from alopecia aerate in cases which do not have the usual peribulbar lymphocytic infiltrate and showed that CD3+ T-lymphocytes within the empty fibrous follicular tracts favor a diagnosis of alopecia areata. We performed CD123 in order to distinguish lichen planopilaris from alopecia lupus erythematosus in cases with only a superficial lymphocytic infiltrate and an uninvolved interfollicular epidermis and showed that clusters of CD123+ plasmacytoid dendritic cells favor a diagnosis of lupus erythematosus. We performed cytokeratin 15 in order to assess whether the loss of the follicular bulge stem cells has diagnostic value in cicatricial alopecia and demonstrated that the loss of cytokeratin 15+ bulge stem cells is identified in lichen planopilaris, frontal fibrosing alopecia, and lupus erythematous, so cytokeratin 15 has no diagnostic value. We have attempted to integrate the new concepts and our findings into the traditional classifications of alopecia and proposed a new diagnostic algorithm. In conclusion, immunostaining combined with HoVert grossing advances the accuracy of histopathological diagnosis of primary scalp alopecia.<br>L’alopécie primitive du cuir chevelu est habituellement classée en cicatricielle et non-cicatricielle. Dans les cas difficiles, la biopsie du cuir chevelu peut aider au diagnostic. L’utilisation de coupes, à la fois verticales et horizontales sur le même spécimen (technique HoVert), a radicalement amélioré le diagnostic histopathologique. Dans ce travail, nous avons utilisé l’immunohistochimie pour évaluer les difficultés diagnostiques qui persistent malgré tous les outils actuels. Nous avons utilisé les CD3, CD4, CD8 et CD20 pour différencier l’alopécie androgénique de la pelade dépourvue de l’infiltrat lymphocytaire péribulbaire habituel et nous avons démontré que la présence de lymphocytes CD3+ dans les travées folliculaires fibreuses est en faveur de la pelade. Nous avons utilisé le CD123 pour différencier le lichen plan pilaire du lupus érythémateux alopécie avec infiltrat lymphocytaire superficiel et sans atteinte de l’épiderme interfolliculaire et nous avons démontré que la présence d’amas de cellules dendritiques plasmacytoïdes CD123+ est en faveur du lupus érythémateux. Nous avons utilisé la cytokératine 15 pour évaluer si la perte des cellules souches du bulge a une valeur diagnostique dans l’alopécie cicatricielle et nous avons démontré que cette perte s’observait de manière identique dans le lichen plan pilaire, l’alopécie frontale fibrosante comme dans le lupus érythémateux et n’avait donc aucune valeur diagnostique. Nous avons tenté d’intégrer les nouveaux concepts et nos données dans les classifications traditionnelles des alopécies et nous avons élaboré un nouvel algorithme diagnostique. L’association des immunomarquages avec la technique HoVert ouvre de nouvelles perspectives dans le diagnostic histopathologique des alopécies primaires du cuir chevelu.<br>Doctorat en Sciences médicales (Médecine)<br>info:eu-repo/semantics/nonPublished
APA, Harvard, Vancouver, ISO, and other styles
2

Schlager, Justin Gabriel [Verfasser]. "Topical treatments for scalp psoriasis / Justin Gabriel Schlager." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2016. http://d-nb.info/1119803896/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Iorizzo, Matilde <1975&gt. "The role of scalp dermoscopy in the diagnosis of alopecia areata incognita." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2008. http://amsdottorato.unibo.it/1065/1/Tesi_Iorizzo_Matilde.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Iorizzo, Matilde <1975&gt. "The role of scalp dermoscopy in the diagnosis of alopecia areata incognita." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2008. http://amsdottorato.unibo.it/1065/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pye, Isobel McKellar. "Tools To Reliably Quantify Scalp Hair Density and Greying for Use in Clinical and Research Settings- A Systematic Review and a New Proposal." Thesis, The University of Sydney, 2022. https://hdl.handle.net/2123/29508.

Full text
Abstract:
Background Both hair greying and hair loss (alopecia) have been associated with an increased risk of serious systemic conditions such as cardiovascular disease. However, there has been no systematic review of the reliability of existing tools for the measurement of these aspects of hair. Objectives 1. To systematically review the reliability, usability, convenience, and accuracy of tools for the measurement of hair density and hair greying. 2. To create clinically useful tools for the assessment of hair greying and hair density, and to assess the reliability of these tools. 3. To assess the correlation between the newly developed Hair Density Scale (HDS) (Objective 2) and the commonly used Hamilton-Norwood scale (HNS) to determine if distinct phenotypes of pattern hair loss exist. Methods 1. Literature was extracted from five databases. From each eligible article, scale reliability, usability, convenience, and accuracy were categorised and compared. 2. The Hair Greying Scale (HGS) and the HDS were created using Photoshop and Adobe Illustrator respectively. The reliability of the scales was assessed. 3. The HDS was compared to the HNS on a total of 101 male subjects. Cluster analysis on HDS data was performed. Results 1. The Scalp Coverage Score and the Dermoscopy-derived Semi-quantitative Density Scales were the most reliable scales for assessing pattern hair loss. The ‘Alopecia Areata Progression Index’, ‘Marginal Traction Alopecia Severity Score’ and ‘Alopecia Rating’ for trichotillomania were all reliable scales for the assessment of their respective conditions. For assessing generic hair density, both manual and automated hair counts were reliable options. The only eligible hair greying assessment tool was the ‘Graying Severity Score’ which had good reliability. 2. Two novel scales were created, the HDS and HGS, which both had good reliabilities. 3. There was a good correlation between the HNS and HDS readings in the frontal and vertex scalp areas, but not with the occipital and temporal areas. Distinct phenotypes of pattern hair loss were not identifiable. Conclusions 1. This is the first systematic comparison of the reliability, usability, convenience, and accuracy of existing scales for the assessment of hair density and hair greying. 2. Pictorial classifications of pattern hair loss (PHL) such as the Hamilton-Norwood Scale are unreliable even when used by expert appraisers despite having deemed certain categories of PHL to increase an individual’s risk of cardiovascular disease. 3. The newly created HDS and HGS are reliable and clinically useful. 4. Cluster analysis using data generated from the HDS did not confirm that distinct, numerically quantifiable hair loss patterns exist. 5. With the newly introduced method and tools, it is now possible to assess alopecia based on semi-quantifiable measurements of hair density in any scalp region.
APA, Harvard, Vancouver, ISO, and other styles
6

Walonski, Christopher. "Skin Deep: Body Modification and Agentic Identities Among Women with Skin Conditions." Digital Commons @ East Tennessee State University, 2021. https://dc.etsu.edu/etd/3906.

Full text
Abstract:
This study explores processes of identity construction among women who have skin conditions and body modifications. Analyzing seven semi-structured qualitative interviews, the author examines how individuals affected by skin conditions employ body modification practices to organize their identities and promote feelings of agency across both personal and social domains. Engaging a Bakhtinian dialogic lens, the author argues that body modification may operate as a de-stigmatization strategy that supports individuals with skin conditions in cultivating a sense of self-determination and bodily sovereignty. Shaped by grounded theory, this study’s findings trace relationships between body modification and the development of agentic identities among women with skin conditions. Confronted by medical, physical, and social disenfranchisement, women affected by skin conditions may implement body modification practices to navigate treatment, incorporate their conditions, and negotiate their relationships. The author additionally suggests implications for the application of body modification practices as somatic therapeutic modalities.
APA, Harvard, Vancouver, ISO, and other styles
7

Al-Waleedi, Saeed A. "The roles of hepatocyte growth factor family members in androgen-regulation of human hair growth : a comparison of the expression of hepatocyte growth factor family members, HGF and MSP, and their receptors, c-Met and RON, in isolated hair follicles from normal and androgenetic alopecia (balding) scalp." Thesis, University of Bradford, 2010. http://hdl.handle.net/10454/5271.

Full text
Abstract:
Androgens are the main regulators of human hair growth stimulating larger, terminal hair development e.g. beard and causing scalp balding, androgenetic alopecia. Hair disorders cause psychological distress but are poorly controlled. Androgens probably act by altering regulatory paracrine factors produced by the mesenchyme-derived dermal papilla. This study aimed to investigate paracrine factors involved in androgen-regulated alopecia, particularly hepatocyte growth factor (HGF) family members, by investigating their in vivo status. Balding and non-balding scalp hair follicles and their component tissues were isolated and analysed by molecular biological methods (reverse transcriptase-polymerase chain reaction (RT-PCR), quantitative PCR and DNA microarray analysis), cell culture and immunohistochemistry. Scalp follicles expressed a range of paracrine messenger genes. The dermal papilla, cultured dermal papilla cells and dermal sheath expressed several HGF family genes, while matrix cells only produced the receptor RON suggesting autocrine roles for HGF and MSP, but a paracrine route only for MSP. Comparing balding and non-balding follicles from the same individuals revealed the expected reduction in several keratin and keratin-related protein genes supporting this approach's validity. There were also significant differences in paracrine factors previously implicated in androgen action by in vitro studies. Several factors believed to increase during androgen stimulation of larger, darker follicles, e.g. IGF-I and SCF, were lowered in balding follicles, while putative inhibitory factors, e.g. TGFß-1, were increased. HGF and MSP and their receptors, c-Met and RON, were significantly reduced. These results increase our understanding of androgen action in human hair follicles; this could lead to better treatments for hair disorders.
APA, Harvard, Vancouver, ISO, and other styles
8

Khidhir, K. G., D. F. Woodward, N. P. Farjo, et al. "The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias." 2013. http://hdl.handle.net/10454/6050.

Full text
Abstract:
Balding causes widespread psychological distress but is poorly controlled. The commonest treatment, minoxidil, was originally an antihypertensive drug that promoted unwanted hair. We hypothesized that another serendipitous discovery, increased eyelash growth side-effects of prostamide F(2alpha)-related eyedrops for glaucoma, may be relevant for scalp alopecias. Eyelash hairs and follicles are highly specialized and remain unaffected by androgens that inhibit scalp follicles and stimulate many others. Therefore, we investigated whether non-eyelash follicles could respond to bimatoprost, a prostamide F(2alpha) analog recently licensed for eyelash hypotrichosis. Bimatoprost, at pharmacologically selective concentrations, increased hair synthesis in scalp follicle organ culture and advanced mouse pelage hair regrowth in vivo compared to vehicle alone. A prostamide receptor antagonist blocked isolated follicle growth, confirming a direct, receptor-mediated mechanism within follicles; RT-PCR analysis identified 3 relevant receptor genes in scalp follicles in vivo. Receptors were located in the key follicle regulator, the dermal papilla, by analyzing individual follicular structures and immunohistochemistry. Thus, bimatoprost stimulates human scalp follicles in culture and rodent pelage follicles in vivo, mirroring eyelash behavior, and scalp follicles contain bimatoprost-sensitive prostamide receptors in vivo. This highlights a new follicular signaling system and confirms that bimatoprost offers a novel, low-risk therapeutic approach for scalp alopecias.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Alopecia and scalp psoriasis"

1

F, Camacho Martínez, Price Vera H, and Randall Valerie A, eds. Hair and its disorders: Biology, pathology and management. Martin Dunitz, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Berker, David de. Hair disorders. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0253.

Full text
Abstract:
This chapter discusses inflammatory scalp diseases and hair shedding (telogen effluvium and pattern hair loss). Inflammatory diseases of the scalp can affect all epidermal surfaces or focus upon the follicle, with relative sparing of the interfollicular skin. Eczema and psoriasis are examples of the former; other diseases, such as lichen planopilaris or discoid lupus erythematosus, are examples of the latter. Some follicular diseases, such as the family of diseases based on alopecia areata (alopecia areata (small areas of hair loss), alopecia totalis (whole scalp), and alopecia universalis (whole body)), cause barely visible follicular inflammation which results in hair loss but no scarring. Some patients present with hair shedding or change of hair pattern as their primary complaint, with no scalp disease; this is telogen effluvium. Others present with an altered pattern of scalp hair without conspicuous shedding; this is pattern hair loss.
APA, Harvard, Vancouver, ISO, and other styles
3

Ronda, Odell. Understand Psoriasis : Self-Confident Without Psoriasis: Psoriasis Scalp. Independently Published, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Spannuth, Shantel. Dealing with Psoriasis : the Natural Diet to Cope with Skin Psoriasis and Scalp Psoriasis: How to Cure Scalp Psoriasis Naturally. Independently Published, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Morquecho, Troy. Psoriasis Causes : What Is Psoriasis and How Do You Treat It: Psoriasis Scalp. Independently Published, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Barok, Ziggy. How I Successfully Treated My Scalp Psoriasis. Independently Published, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Graef, Adam. Coloring Book - You Will Get Better - Scalp Psoriasis. Independently Published, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Graef, Adam. Coloring Book - You Will Get Better - Scalp Psoriasis. Independently Published, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kisak, Alex. How to Treat Psoriasis? : Guide to Natural Diet to Cure Skin Psoriasis and Scalp Psoriasis: Skin Cap Psoriasis Treatment. Independently Published, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Culvert, L. Lee. Women and Alopecia: Managing Unexplained Hair Loss. Your Health Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Alopecia and scalp psoriasis"

1

Lewis, Daniel J., and Steven R. Feldman. "Scalp Psoriasis." In Practical Ways to Improve Patient Adherence, 2nd ed. CRC Press, 2023. http://dx.doi.org/10.1201/9781003367628-32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Asz-Sigall, Daniel, and Antonella Tosti. "Scalp Psoriasis." In Hair and Scalp Treatments. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-21555-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Miteva, Mariya. "Scalp Psoriasis." In Hair Pathology with Trichoscopic Correlations. CRC Press, 2021. http://dx.doi.org/10.1201/9780429457609-23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fan, Jincai, Liqiang Liu, and Jia Tian. "Scalp Alopecia Reconstruction." In Color Atlas of Burn Reconstructive Surgery. Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-05070-1_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Inaba, Masumi, and Yoshikata Inaba. "Regeneration of Scalp Hair." In Androgenetic Alopecia. Springer Japan, 1996. http://dx.doi.org/10.1007/978-4-431-67038-4_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Anastassakis, Konstantinos. "Scalp Micropigmentation." In Androgenetic Alopecia From A to Z. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-10613-2_35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Anastassakis, Konstantinos. "Scalp Flaps." In Androgenetic Alopecia From A to Z. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-10613-2_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Anastassakis, Konstantinos. "Scalp Reduction." In Androgenetic Alopecia From A to Z. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-10613-2_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Anastassakis, Konstantinos. "Scalp Expansion." In Androgenetic Alopecia From A to Z. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-10613-2_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Anastassakis, Konstantinos. "Scalp Lifting." In Androgenetic Alopecia From A to Z. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-10613-2_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Alopecia and scalp psoriasis"

1

Ji, Honghai, Jiaqi Li, Weiwei Jiang, Li Wang, Shida Liu, and Yang Chen. "Recognition of Scalp Psoriasis Dermoscopic Patterns Signs Based on Histogram Equalization and Convolutional Neural Networks." In 2024 IEEE 13th Data Driven Control and Learning Systems Conference (DDCLS). IEEE, 2024. http://dx.doi.org/10.1109/ddcls61622.2024.10606920.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jamale, Varsha, Fatima Sanjeri Dasankoppa, Ravij Shah, and Rohan S. Phatak. "Efficiency Assessment of Intralesional Platelet-Rich Plasma Therapy for Scalp Alopecia Areata: A Randomized Comparative Single-Blinded Study." In 2024 International Conference on Healthcare Innovations, Software and Engineering Technologies (HISET). IEEE, 2024. http://dx.doi.org/10.1109/hiset61796.2024.00019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kammerer, Susanne. "Alopecia areata: Ritlecitinib generates substantial re-growth of scalp hair." In EADV Congress 2023, edited by Peter van de Kerkhof. Medicom Medical Publishers, 2023. http://dx.doi.org/10.55788/ded65e11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

van Leeuwen, Gerard M. J., Anton A. van Steenhoven, and Francis-Paul E. M. Janssen. "Numerical Simulation of Scalp Cooling to Prevent Chemotherapy-Induced Alopecia." In Thermal Sciences 2004. Proceedings of the ASME - ZSIS International Thermal Science Seminar II. Begellhouse, 2004. http://dx.doi.org/10.1615/ichmt.2004.intthermscisemin.400.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nangia, JR, T. Wang, PA Niravath, et al. "Abstract S5-02: Scalp cooling alopecia prevention trial (SCALP) for patients with early stage breast cancer." In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-s5-02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ciuchita, Tavi, Mircea Usurelu, and Ciprian Antipa. "Low-energy laser in the treatment of alopecia of the scalp." In BiOS Europe '97, edited by Tiina I. Karu and Anthony R. Young. SPIE, 1997. http://dx.doi.org/10.1117/12.297999.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nangia, JR, T. Wang, M. Rude, et al. "Abstract OT3-02-08: Scalp cooling alopecia prevention trial (SCALP) for patients with early stage breast cancer." In Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-ot3-02-08.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wills, S., A. Ravipati, M. Nguyen, et al. "Scalp Hypothermia Minimizes Alopecia in Breast Cancer Patients Receiving Non-Anthracycline Adjuvant Chemotherapy." In Abstracts: Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 10‐13, 2009; San Antonio, TX. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-09-5040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Schorn, Patrícia Werlang, Juçara Motta Serafim Eliam, André Moreira Lemes, et al. "EXPERIENCE OF A PRIVATE HOSPITAL IN THE FEDERAL DISTRICT IN CRYOTHERAPY WITH A HYPOTHERMAL CAP FOR PATIENTS USING PACLITAXEL 80 MG/M² WEEKLY FOR 12 WEEKS." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2082.

Full text
Abstract:
Objective: Chemotherapy-induced alopecia (CIA) has a major impact on oncological patients and is reported as one of the first concerns among women, being often a condition that causes suffering. CIA is an expected adverse event in paclitaxel, an agent widely used in the treatment of breast cancer. Strategies have been used to minimize this undesirable effect, including the scalp cooling. The objective of our study was to report the frequency of the preservation of hair volu me in women who used a monodrug called “paclitaxel” at a dose of 80 mg/m²/week for 12 weeks, using a hypothermic glycerinbased hydrogel cap in a private institution in the federal district. Methods: This descriptive retrospective study included 92 women with no evidence of alopecia at the beginning of monotherapy treatment with paclitaxel 80 mg/m2 /week for 12 weeks. They used a hypothermic glycerin-based hydrogel cap during the infusion of the drug. The quantification of alopecia was performed using the modified Dean scale and Common Terminology Criteria for Adverse Events version 4 (CTCAEv4). The patient characteristics such as age, type of hair, purpose of treatment, site of primary neoplasm were described. Results: From 2014 to 2018, 86 (93.5%) of the 92 patients who were included in the study had breast cancer. At the end of the 12 weeks of treatment, 83% of patients developed grade 1 alopecia by CTCAEv4. According to the modified Dean scale, 71% of patients were classified as alopecia grade 1, 12% as grade 2, 7.5% as grade 3, and 9.5% as grade 4. Conclusion: More than 80% of women, who were treated with paclitaxel weekly and used the hypothermic glycerin-based hydrogel cap, had at least 50% of their initial hair volume preserved by the two scales. These results suggest the effectiveness of the scalp cooling therapy in preventing CIA, being an important strategy to be considered to minimize the impact on the appearance and emotional damage caused by alopecia in these patients.
APA, Harvard, Vancouver, ISO, and other styles
10

Sheikholeslami, Mohamad, Ahmadreza Faghih Khorasani, Mahsa Ghaffari, and Mohamad Zoghi. "Prevention of chemotherapy-induced alopecia by scalp cooling: the study of perfusion and tissue metabolism." In 2015 22nd Iranian Conference on Biomedical Engineering (ICBME). IEEE, 2015. http://dx.doi.org/10.1109/icbme.2015.7404128.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Alopecia and scalp psoriasis"

1

Gupta, Aditya, Tong Wang, Shruthi Ravi, Mesbah Talukder, Jessie Carviel, and Mary Bamimore. Relative efficacy of microneedling in the treatment of pattern hair loss: a protocol for a systematic review with network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.9.0042.

Full text
Abstract:
Review question / Objective: The objective of the proposed study is to determine the relative efficacy of microneedling and combination of it and other agents for androgenetic alopecia (AGA)—a condition that is also referred to as pattern hair loss. Rationale: Pattern hair loss is one of the most common forms of hair loss in men and women; the condition is associated with decreased quality of life. Oral finasteride and topical minoxidil are treatments currently approved, by the United States Food and Drug Administration, for AGA. However, finasteride has been associated with significant side effects in men, and is not appropriate for women of childbearing potential. Furthermore, topical minoxidil requires daily prolonged use which is time-consuming for patients and requires high compliance to maintain efficacy. Due to these drawbacks, new treatments, such as microneedling, have been investigated. Microneedling involves the creation of small wounds on the scalp that prompt growth factor release and neovascularization—which, in turn, may promote hair growth. Microneedling has been used as a monotherapy—or in combination with other standard therapies—for the treatment of AGA. Further investigation through meta-analysis is salient as this quantitative technique can estimate the relative success of mono- and poly-therapy with microneedling; therefore, findings from a systematic review and meta-analysis on the comparative effectiveness can enable clinicians, patients, and researchers to make more informed decisions.
APA, Harvard, Vancouver, ISO, and other styles
2

Topical steroids better than vitamin D for treating scalp psoriasis. National Institute for Health Research, 2016. http://dx.doi.org/10.3310/signal-000254.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Alopecia and scalp psoriasis' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography